[HTML][HTML] SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies
L Huang, Y Rong, Q Pan, K Yi, X Tang, Q Zhang… - Asian Journal of …, 2021 - Elsevier
The development of a massively producible vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies
L Huang, Y Rong, Q Pan, K Yi… - Asian journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
The development of a massively producible vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies
L Huang, Y Rong, Q Pan, K Yi, X Tang, Q Zhang… - 2021 - hero.epa.gov
The development of a massively producible vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies.
L Huang, Y Rong, Q Pan, K Yi, X Tang… - Asian Journal of …, 2021 - search.ebscohost.com
The development of a massively producible vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
[HTML][HTML] SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies
L Huang, Y Rong, Q Pan, K Yi, X Tang… - Asian Journal of …, 2021 - ncbi.nlm.nih.gov
The development of a massively producible vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies.
L Huang, Y Rong, Q Pan, K Yi, X Tang… - Asian Journal of …, 2020 - europepmc.org
The development of a massively producible vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies
L Huang, Y Rong, Q Pan, K Yi, X Tang, Q Zhang… - 2020 - expeditiorepositorio.utadeo.edu.co
The development of a massively producible vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies
L Huang, Y Rong, Q Pan, K Yi, X Tang, Q Zhang… - 2020 - expeditiorepositorio.utadeo.edu.co
The development of a massively producible vaccine against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …
syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the …